• Offer for Industry
  • Young GI
  • Patients
  • Press
  • Newsletter
  • Contact us
UEG Logo
UEG Connect
Create myUEG account
  • About
    • To landing page
      • Who we are
      • Boards, Committees & Groups
      • Governance
      • Headquarters Management
      • History
      • What we do
      • Strategic Drivers
      • Year in Review
      • Our Members
      • Specialist Member Societies
      • National Member Societies
      • UEG Community
      • UEG Associates
      • UEG Connect
      • Women in GI
      • Young GIs
      • Researchers
      • Event Calendar
  • Week
    • To landing page
      • Attendance
      • Registration fees
      • Hotel
      • Venue
      • Congress Platform
      • Helpful info
      • Eco-friendly info
      • Programme
      • Abstract Submission
      • DDM Summit
      • Nurse Programme
      • Postgraduate Teaching
      • Industry
      • Supporters
      • Congress Resources
      • UEG Week Recordings ↗
      • CME Accreditation
      • Future UEG Week
  • Education
    • To landing page
      • Gutflix - Learning Platform ↗
      • Online Courses ↗
      • Mistakes in... ↗
      • UEG Podcast ↗
      • Webinars ↗
      • Summer School
      • Masterclass
      • Gut Guide
      • CME in Europe
      • Supporters
  • Research
    • To landing page
      • Horizon Europe Support
      • Start-up Grant
      • Research Projects
      • HoloSurge
      • Intercept
      • InfoGut COST Action
      • White Book 2
      • Main Results
      • Full Reports
      • Materials and Presentations
  • Quality of Care
    • To landing page
      • Search Guidelines ↗
      • Non-English Guidelines
      • How to Develop Guidelines ↗
      • Quality of Care Initiatives
      • Quality Indicators
  • Public Affairs
    • To landing page
      • News
      • Focus Areas
      • Advocacy Toolbox
      • Stakeholder Collaboration
      • Digestive Health Month
      • Position Papers
      • Advocacy Bulletin
      • #EUNewsline
      • MEP Digestive Health Group
  • Publications
    • To landing page
      • Congress Publications
      • Research Publications
      • Public Affairs Publications
      • Education Publications
      • UEG Publications
      • UEG Journal ↗
      • UEG Journal Podcast ↗
  • Opportunities
    • To landing page
      • Top Abstract Prizes
      • National Scholarships
      • Travel Grants
      • International Scholarships
      • Research Prize
      • Research Fellowships
      • Lifetime Achievement Award
      • Journal Best Paper Award
      • Activities Endorsement
      • Rising Star Awards
      • Clinical Visiting Fellowships
      • Open Positions
      • Registration for interest
  • Gutflix ↗
  • Offer for Industry
  • Young GI
  • Patients
  • Press
  • Newsletter
  • Contact us
Decide on the Spot

One finding and two surprises

November 16, 2017 | Bjorn Rembacken

The gastric polyp seen in the video was discovered in a 65-year-old man who presented with a microcytic anaemia.

Case question 1

What is your Endoscopic diagnosis?

a)    Healing gastric ulcer

b)    Hyperplastic polyp

c)     Gastric inflammatory fibroid polyp

d)    Gastric adenoma

e)    Gastric cancer

  • Answer to case question 1 and discussion
Answer to case question 1 and discussion

Correct answer: e.

Discussion

This is a somewhat peculiar looking gastric lesion that is composed of a pale part and more erythematous, indurated part. The lesion is clearly malignant and has an ominous-looking nodularity in the centre and a more infiltrative edge.

The pale part of the lesion corresponded to the poorly differentiated part of this gastric cancer, whilst the moderately differentiated part of the cancer corresponded to the more erythematous part.

The photographs below show the histological findings for the lesion and reveal something unexpected.

Case question 2

What is the unexpected finding revealed by the histology?

a.     This cancer is limited to the mucosa

b.     There is lymphovascular infiltration

c.     This is likely to be a metastatic deposit

d.     The cancer has undergone neuroendocrine differentiation

e.     The cancer appears to have arisen from within a gastrointestinal stromal tumour (GIST)

  • Answer to case question 2 and discussion
Answer to case question 2 and discussion

Correct answer: d.

Discussion

The dark purple, angular cell clusters indicate the poorly differentiated adenocarcinoma. In the bottom images several more round and purple deposits are seen that are composed of large dark cells. These cells are neuroendocrine cells. Mixed adenoneuroendocrine carcinoma (MANEC) is a rare gastrointestinal tumour that consists of both an adenocarcinomatous component and a neuroendocrine component that comprises at least 30% of the tumour.  Prior to the introduction of the term mixed adenoneuroendocrine carcinoma in 2010, these lesions were reported as a mixed or composite tumour.1

This kind of neoplasm is aggressive and usually has a poor prognosis, presumably because both components are malignant.2 Typically, the neuroendocrine portion of the neoplasm is grade 3 with >20 mitoses per 10 high-powered fields (HPF) and/or a Ki-67 proliferative index of >20%.  The only hope of cure is offered by gastrectomy. In patients who have advanced disease platinum-based chemotherapy, such as a combination of cisplatin and etoposide, has been recommended.

References

  1. Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system In: Bosman FT, Carneiro F, Hruban RH and Theise ND (eds) WHO Classification of Tumours of the Digestive System. Lyon, IARC Press, 2010, pp. 13–14. http://apps.who.int/bookorders/WHP/detart1.jsp?sesslan=1&codlan=1&codcol=70&codcch=4003
  2. Fukuba N, et al. Gastric mixed adenoneuroendocrine carcinoma with a good prognosis. Intern Med 2014; 53: 2585–2588. https://www.jstage.jst.go.jp/article/internalmedicine/53/22/53_53.3328/_article
Social Sharing
  • About the Author
About the Author

Bjorn Rembacken is at Leeds Teaching Hospitals NHS Trust, Leeds, UK. He was born in Sweden and qualified from Leicester University in 1987. He undertook his postgraduate education in Leicester and in Leeds. His MD was dedicated to inflammatory bowel disease. Dr Rembacken was appointed Consultant Gastroenterologist, Honorary Lecturer at Leeds University and Endoscopy Training Lead in 2005. Follow Bjorn on Twitter @Bjorn_Rembacken

Comment

Please log in with your myUEG account to post comments.

Get our newsletter!
Sign up with your email to receive UEG news and updates. We respect your privacy.

Headquarters Management

United European Gastroenterology

Wickenburggasse 1
1080 Vienna, Austria



T: +43 1 997 1639

UEG Week Registration

Mondial Congress & Events

Official UEG Week Registration Partner
Operngasse 20b
1040 Vienna, Austria



T: +43 1 58804 - 0

More

Imprint

Terms & Conditions

Media Policies

Privacy Policy

Accessibility Statement

Change cookie-settings

Social Media

7 767 Followers

26 000 Followers

16 200 Followers

7 400 Followers

3 670 Subscribers

15 000 Subscribers

65 Subscribers

597 Subscribers

UEG copyright 2026. All rights reserved. Use of this website constitutes acceptance of the Privacy Policy and Terms & Conditions.